A systematic review of biosynthesized metallic nanoparticles as a promising anti-cancer-strategy

A Andleeb, A Andleeb, S Asghar, G Zaman, M Tariq… - Cancers, 2021 - mdpi.com
Simple Summary Cancer is one of the major public health burdens in the world. To date,
various conventional cancer therapies have been used, but these therapies are less …

Artificial intelligence-based prediction of clinical outcome in immunotherapy and targeted therapy of lung cancer

X Yin, H Liao, H Yun, N Lin, S Li, Y Xiang… - Seminars in cancer biology, 2022 - Elsevier
Lung cancer accounts for the main proportion of malignancy-related deaths and most
patients are diagnosed at an advanced stage. Immunotherapy and targeted therapy have …

[HTML][HTML] Dual role of reactive oxygen species and their application in cancer therapy

R Huang, H Chen, J Liang, Y Li, J Yang, C Luo… - Journal of …, 2021 - ncbi.nlm.nih.gov
Reactive oxygen species (ROS) play a dual role in the initiation, development, suppression,
and treatment of cancer. Excess ROS can induce nuclear DNA, leading to cancer initiation …

Fisetin in cancer: attributes, developmental aspects, and nanotherapeutics

RM Kumar, H Kumar, T Bhatt, R Jain, K Panchal… - Pharmaceuticals, 2023 - mdpi.com
Cancer is one of the major causes of mortality, globally. Cancerous cells invade normal cells
and metastasize to distant sites with the help of the lymphatic system. There are several …

Roles of non-canonical structures of nucleic acids in cancer and neurodegenerative diseases

H Tateishi-Karimata, N Sugimoto - Nucleic Acids Research, 2021 - academic.oup.com
Cancer and neurodegenerative diseases are caused by genetic and environmental factors.
Expression of tumour suppressor genes is suppressed by mutations or epigenetic silencing …

[HTML][HTML] Immunomodulatory effect of mushrooms and their bioactive compounds in cancer: A comprehensive review

MP Pathak, K Pathak, R Saikia, U Gogoi… - Biomedicine & …, 2022 - Elsevier
Despite enormous development in the field of drug development, cancer still remains
elusive. Compromised immunity stands as a roadblock to the successful pharmacological …

Advancement in biopolymer assisted cancer theranostics

T Bhattacharya, S Preetam, B Ghosh… - ACS Applied Bio …, 2023 - ACS Publications
Applications of nanotechnology have increased the importance of research and
nanocarriers, which have revolutionized the method of drug delivery to treat several …

Glimmers of hope for targeting oncogenic KRAS-G12D

D Tang, R Kang - Cancer Gene Therapy, 2023 - nature.com
KRAS mutations are one of the most common genetic abnormalities in cancer, especially
lung, colon, and pancreatic cancers. Strategies targeting the oncogenic KRAS pathway …

Flavonoids: A myth or a reality for cancer therapy?

C Forni, M Rossi, I Borromeo, G Feriotto, G Platamone… - Molecules, 2021 - mdpi.com
Nutraceuticals are biologically active molecules present in foods; they can have beneficial
effects on health, but they are not available in large enough quantities to perform this …

Global epidemiology of breast cancer based on risk factors: a systematic review

A Roheel, A Khan, F Anwar, Z Akbar, MF Akhtar… - Frontiers in …, 2023 - frontiersin.org
Background Numerous reviews of the epidemiology and risk factors for breast cancer have
been published previously which heighted different directions of breast cancer. Aim The …